Exercise to Augment TMS in Those With Treatment Resistant Depression
Given the growing evidence that aerobic increases cortical excitability and promotes neuroplasticity, the scientific premise for its potential priming effect on the brain is strong. Combining AE with rTMS may produce a neural environment optimized for a robust physiological effect of rTMS, thereby leading to improved depression outcomes. With positive findings, this study would provide preliminary support for an innovative, safe and feasible approach for improving outcomes for this significant public health problem.
Conditions:
🦠 Treatment Resistant Depression
🗓️ Study Start (Actual) 1 February 2024
🗓️ Primary Completion (Estimated) 30 August 2024
✅ Study Completion (Estimated) 31 January 2025
👥 Enrollment (Estimated) 30
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Providence, Rhode Island, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * adult outpatients (age 18 and above) who are already approved to receive standard TMS therapy through the Butler Hospital TMS clinic.
    • * able to safely engage in moderate-intensity aerobic exercise (determined by a study physician)

    Exclusion Criteria:

    • * Currently pregnant or plans to become pregnant in the next 6 weeks
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 12 June 2023
  • First Submitted that Met QC Criteria 12 June 2023
  • First Posted 22 June 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 11 March 2024
  • Last Update Posted 13 March 2024
  • Last Verified March 2024